%0 Figure %A Lohberger, Birgit %A Rinner, Beate %A Stuendl, Nicole %A Kaltenegger, Heike %A Steinecker-Frohnwieser, Bibiane %A Bernhart, Eva %A Bonyadi Rad, Ehsan %A Martina Weinberg, Annelie %A Leithner, Andreas %A Bauer, Rudolf %A Kretschmer, Nadine %D 2013 %T Western blot analysis of p53 and the CDK inhibitor p27Kip1 proteins. %U https://plos.figshare.com/articles/figure/_Western_blot_analysis_of_p53_and_the_CDK_inhibitor_p27_Kip1_proteins_/722069 %R 10.1371/journal.pone.0066300.g005 %2 https://plos.figshare.com/ndownloader/files/1089431 %K Biochemistry %K drug discovery %K biotechnology %K Molecular cell biology %K Cell death %K cell division %K Cell growth %K cytometry %K Plant science %K medicinal chemistry %K Drugs and devices %K Drug research and development %K pharmacokinetics %K oncology %K Basic cancer research %K metastasis %K Cancer treatment %K Chemotherapy and drug treatment %K Complementary and alternative medicine %K Cancers and neoplasms %K Bone and soft tissue sarcomas %K Oncology agents %K blot %K p53 %K cdk %K inhibitor %X

Total protein analysis confirmed no significant changes in the p53 expression after costunolide or dehydrocostus lactone treatment. In dehydrocostus lactone treated TE-671 and SW-872 cells, the expression of the CDK inhibitor p27Kip1 was reduced. β-actin was used as loading control. Data shown are representative from at least three independent experiments.

%I PLOS ONE